GLP-1, GLP-2, and the Next Generation of Weight Loss Drugs
Understanding the Science Behind Today’s GLP Medications and Why Evidence Should Always Come Before Marketing
Over the past several years, GLP medications have become one of the most talked-about topics in healthcare. What began with conversations surrounding GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound have quickly expanded into discussions about GLP-2 and even newer investigational medications that many people are referring to as the next generation of weight loss drugs. In some circles, you’ll even hear the term “GLP-3” being used, despite the fact that it isn’t an official scientific classification. Regardless of what they’re called, these medications are generating enormous interest, countless opinions, and unfortunately, a tremendous amount of confusion.
As someone who has spent more than 45 years studying nutrition, metabolism, exercise physiology, and human health, I completely understand why people are paying attention. Obesity, type 2 diabetes, insulin resistance, and other metabolic diseases continue to affect millions of people throughout the world, and medical science has made remarkable advances in developing therapies that can improve health outcomes. Many of these medications have been life-changing for people living with chronic disease, and there is absolutely nothing wrong with scientific innovation when it is supported by good evidence and used appropriately.
What concerns me isn’t the science behind these medications. My concern is with marketing getting ahead of the science.
Unfortunately, social media has once again created an environment where almost anyone can position themselves as a health expert. Every day I see influencers, wellness coaches, MLM representatives, and individuals with little or no formal education confidently explaining how these medications work, recommending protocols, discussing dosages, and encouraging others to purchase products through affiliate links, med spas, or online peptide companies. Some are promoting medications that have been extensively studied and approved for very specific medical conditions, while others are discussing investigational compounds that are still undergoing clinical trials. To the average consumer, it all begins to sound the same, and that’s where misinformation can become dangerous.
Before anyone considers taking any GLP medication or peptide therapy, it’s important to understand exactly what these compounds are, how they work, what they were designed to treat, and just as importantly, what they have not yet been proven to do.
Understanding GLP-1
GLP-1 stands for glucagon-like peptide-1, a hormone naturally produced by specialized cells within the small intestine after we eat. One of its primary responsibilities is helping regulate blood sugar by stimulating insulin release when blood glucose levels begin to rise. It also suppresses glucagon, a hormone that raises blood sugar, slows the rate at which food leaves the stomach, and communicates with areas of the brain involved in appetite regulation and satiety.
Scientists recognized that by developing medications that mimic the action of GLP-1, they could help people better manage type 2 diabetes while also improving weight loss. Years of clinical research confirmed exactly that. Today, medications such as semaglutide and tirzepatide have become valuable tools in the treatment of obesity and diabetes because they address several of the underlying physiological mechanisms involved in these diseases rather than simply masking symptoms.
It’s important to understand, however, that these medications are tools, not cures. While they can significantly reduce appetite and improve blood sugar control, they do not replace the importance of proper nutrition, adequate protein intake, resistance training, physical activity, quality sleep, and long-term lifestyle modification. In fact, research consistently demonstrates that people who combine medication with healthy lifestyle habits generally experience better long-term outcomes than those who rely on medication alone.
This distinction is incredibly important because many people mistakenly believe that if the medication is working, the lifestyle no longer matters. In reality, preserving muscle mass, maintaining metabolic health, improving cardiovascular fitness, and reducing long-term disease risk still depend heavily on the choices we make every day.
Understanding GLP-2
This is where many people begin to get confused.
Although GLP-2 sounds remarkably similar to GLP-1, it performs a completely different job within the body. Rather than primarily influencing appetite and blood sugar regulation, GLP-2 is responsible for supporting the health, growth, and function of the intestinal lining. It helps stimulate the growth of intestinal cells, improves the intestine’s ability to absorb nutrients and fluids, strengthens the intestinal barrier, and helps maintain the integrity of the digestive tract.
Because of these unique properties, GLP-2 medications were developed to treat a very specific medical condition known as short bowel syndrome. This condition typically occurs after significant portions of the small intestine have been surgically removed due to disease or injury. Individuals living with short bowel syndrome often struggle to absorb adequate nutrition and fluids, making GLP-2 therapy an important medical advancement that can dramatically improve quality of life.
Unfortunately, somewhere along the way, the message began to change.
Because GLP-2 supports intestinal health, many people have started assuming that taking a GLP-2 medication will automatically improve gut health in healthy individuals, reverse digestive disorders, slow aging, enhance metabolism, or optimize overall wellness. While these claims may sound exciting, they simply are not supported by the current body of scientific evidence.
At this time, GLP-2 has not been established as a general health optimization therapy for healthy adults. Its FDA-approved use remains limited to a very specific medical condition, and that distinction is one consumers should clearly understand before believing many of the claims circulating online.
Why Scientists Continue Developing New GLP Medications
One of the most common questions people ask is, “If GLP-1 medications are working so well, why are researchers already developing newer drugs?”
The answer lies in understanding just how incredibly complex human metabolism really is.
For many years, scientists believed obesity was simply the result of eating too much and exercising too little. Today, we know it’s far more complicated than that. Body weight is regulated by an intricate network of hormones, neurotransmitters, organs, and feedback systems that constantly communicate with one another. Appetite, blood sugar regulation, fat storage, energy expenditure, satiety, and even food cravings are influenced by dozens of biological signals working together every second of every day.
GLP-1 is only one piece of that much larger puzzle.
While GLP-1 medications have produced impressive results for many people, researchers quickly recognized that other hormones also play important roles in regulating metabolism. Rather than asking whether one hormone was better than another, scientists began asking a different question.
What if multiple metabolic pathways could be influenced at the same time?
That question has driven much of today’s pharmaceutical research.
One example is tirzepatide, the active ingredient in Mounjaro and Zepbound. Unlike semaglutide, which primarily targets the GLP-1 receptor, tirzepatide activates both the GLP-1 and GIP receptors. GIP, which stands for glucose-dependent insulinotropic polypeptide, is another naturally occurring hormone involved in blood sugar regulation, insulin secretion, and energy metabolism. By targeting both receptors simultaneously, researchers were able to produce even greater improvements in blood sugar control and body weight than had previously been observed with GLP-1 therapy alone.
The next generation of investigational medications takes this concept one step further.
Drugs such as retatrutide are being studied because they stimulate three different hormone receptors simultaneously: GLP-1, GIP, and the glucagon receptor. Each receptor influences metabolism in a slightly different way, and researchers are exploring whether activating all three together can produce even greater improvements in obesity, type 2 diabetes, fatty liver disease, and overall metabolic health.
This is an exciting area of medical research, and the early clinical results have certainly attracted attention. However, excitement alone is never enough.
Every promising medication must still demonstrate that it is safe, effective, and appropriate for long-term use. Researchers must evaluate not only how much weight people lose, but also how these medications affect lean muscle mass, nutritional status, cardiovascular health, gastrointestinal function, quality of life, and potential long-term side effects. Those answers only come from carefully designed clinical trials conducted over many years.
That is exactly why the FDA approval process exists.
The goal isn’t to slow innovation. The goal is to protect patients by ensuring that medications entering the marketplace have been thoroughly evaluated for both safety and effectiveness. While it’s encouraging to see medical science continuing to advance, it’s equally important to remember that newer doesn’t automatically mean better.
As consumers, we should absolutely appreciate scientific innovation. At the same time, we should allow the science to mature before assuming every new medication represents the next miracle breakthrough. History has taught us that the most informed healthcare decisions are made when evidence leads the conversation, not excitement or marketing.
The Next Generation of Weight Loss Drugs
Medical science never stands still. As researchers continue to learn more about the hormones that regulate hunger, metabolism, blood sugar, and energy balance, pharmaceutical companies are developing newer medications designed to target multiple biological pathways simultaneously. The goal is to produce even greater improvements in weight loss, metabolic health, and disease management than what has been achieved with today’s GLP-1 medications.
One of the most talked-about investigational medications is retatrutide. Unlike today’s GLP-1 medications, retatrutide is designed to activate three different hormone receptors simultaneously. It targets the GLP-1 receptor, the GIP receptor, and the glucagon receptor. Because it stimulates three separate metabolic pathways, many people have loosely begun referring to it as a “GLP-3” medication. Scientifically speaking, however, that term is not accurate. There is no hormone called GLP-3. Rather, these medications are considered triple receptor agonists because they activate three different receptors involved in energy regulation and metabolism.
Early clinical trial results have certainly generated excitement within the medical community. In some studies, participants experienced remarkable reductions in body weight, leading many researchers to believe these medications may eventually become another valuable treatment option for obesity and metabolic disease.
However, there is an important point that often gets lost on social media.
As I write this article, retatrutide remains an investigational medication. Although the research is extremely promising, it is still undergoing clinical evaluation and has not yet completed the FDA approval process for general medical use. Until that process is complete, physicians cannot legally prescribe it outside of approved clinical trials.
That hasn’t stopped the internet.
Whenever promising research receives widespread media attention, a market quickly develops for people looking to gain access before the science has fully matured. Unfortunately, we’ve already begun seeing websites, online peptide companies, and some wellness clinics advertising investigational compounds or products marketed as “research peptides” that claim to contain these newer medications.
This is where consumers need to exercise extreme caution.
Products marketed as “research chemicals” or labeled “not for human consumption” are not manufactured under the same strict standards required of FDA-approved pharmaceutical medications. Many bypass important quality control measures, purity testing, standardized dosing, and physician oversight. In some cases, independent laboratory testing has found products containing incorrect concentrations, contaminants, or substances that were entirely different from what was listed on the label.
Simply because something is available for purchase online does not mean it has been proven safe, effective, or appropriate for human use.
That is one of the biggest misconceptions surrounding peptides today.
Medical innovation is exciting, and scientific discovery continues to improve healthcare every year. But there is a tremendous difference between a medication that has successfully completed years of rigorous clinical research and one that is still being investigated. Unfortunately, social media often blurs that distinction, creating the impression that every new compound is ready for widespread use simply because people are talking about it.
Marketing Is Moving Faster Than the Science
This is the part of the conversation I believe deserves the most attention.
My concern isn’t with innovation, medications or even peptides. My concern is with marketing getting ahead of the science.
I’ve watched this happen repeatedly throughout my career. A new supplement, medication, hormone, or peptide begins showing promising results in early research. Before long, social media is flooded with testimonials, influencers begin promoting it, affiliate programs appear, and companies start positioning it as the next miracle breakthrough. Long before researchers have answered all of the important questions, the marketing machine is already in full swing.
Unfortunately, that’s not how science works.
Good science takes time. Researchers must determine not only whether a medication works, but who it works for, what dose is appropriate, what side effects may occur, how it interacts with other medications, whether its benefits outweigh its risks, and what happens after years of continued use. Those questions cannot be answered through social media testimonials or personal opinions. They require carefully designed clinical trials involving thousands of participants over many years.
Consumers deserve better than marketing disguised as medical advice.
That’s why I encourage everyone to approach new therapies with curiosity, but also with healthy skepticism. Ask questions. Read beyond the headlines. Look at the quality of the research, not just the popularity of the product. Most importantly, work with qualified healthcare professionals who understand both the science and your individual medical history.
Questions Every Consumer Should Ask
If you’re considering any GLP medication, peptide, or injectable therapy, I believe it’s important to slow down and ask yourself a few simple questions before making a decision.
Is this medication FDA approved for the condition I’m trying to treat?
Just because a medication exists doesn’t mean it’s appropriate for every condition. Many drugs receive FDA approval for one specific disease or medical condition, yet are later promoted online for dozens of other uses that haven’t been adequately studied. Understanding why a medication was approved is one of the first steps toward making an informed decision.
Is there high-quality human research supporting this specific use?
One of the biggest mistakes people make is confusing preliminary research with established scientific evidence. Laboratory studies, animal research, and early clinical trials all contribute valuable information, but they are only part of the scientific process. Before embracing any new therapy, it’s worth asking whether the evidence comes from large, well-designed human clinical trials or simply from testimonials and social media success stories.
Is it being prescribed and monitored by a qualified healthcare professional?
Every medication has potential benefits, but every medication also carries potential risks. Those risks vary depending on your age, medical history, current medications, and overall health. That’s why these decisions should always be made with a qualified healthcare professional who understands your individual circumstances and can monitor your progress appropriately.
Am I treating a legitimate medical condition, or am I simply chasing the latest trend?
This may be the most important question of all.
The health and fitness industry has always been attracted to the newest trend. Every few years a new supplement, hormone, medication, or therapy captures everyone’s attention and is promoted as the breakthrough, we’ve all been waiting for. While some of these innovations ultimately prove to be valuable additions to medical care, others never live up to the early excitement. Separating legitimate medical need from marketing hype is one of the smartest things any consumer can do.
The Fundamentals Still Matter
One of the biggest misconceptions surrounding GLP medications is the belief that they somehow replace the need for healthy lifestyle habits.
Whether someone chooses to use medication or not, the biological principles that govern human health remain exactly the same.
Our bodies still require adequate protein to build and preserve muscle. They still respond positively to resistance training and regular physical activity. They still benefit from quality nutrition, restorative sleep, effective stress management, and maintaining a healthy body composition.
No medication changes human physiology.
One of the things I emphasize with every client I coach is that medications can certainly become valuable tools when medically appropriate, but they should complement healthy habits rather than replace them. In fact, many people taking GLP medications are at increased risk of losing lean muscle mass as they lose weight. That makes resistance training and adequate daily protein intake even more important than they were before beginning the medication.
This is why I continue to believe that nutrition and exercise remain the foundation of good health. Regardless of what new medications become available over the next five, ten, or twenty years, those fundamentals will continue to play a central role in improving metabolic health, preserving muscle, supporting longevity, and enhancing quality of life.
Bottom Line
Medical science continues to evolve, and that’s something we should all appreciate. New discoveries have the potential to improve countless lives, reduce the burden of chronic disease, and provide treatment options that simply didn’t exist a generation ago. I believe that’s something worth celebrating.
At the same time, scientific progress requires patience. Every new medication must undergo years of careful research to establish not only whether it works, but who it works for, how it should be used, what risks it carries, and whether its long-term benefits outweigh its long-term risks. That process exists for a reason, and it should never be replaced by internet marketing or social media enthusiasm.
I’m not against innovation or medications. In fact, I’m a strong believer in following the science wherever it leads. I simply believe we should let the science lead the conversation, not the marketing. That’s how we protect people, make informed decisions, and ultimately achieve better long-term health appropriately and safely. As consumers, we all have a responsibility to educate ourselves, ask thoughtful questions, and make healthcare decisions based on credible scientific evidence rather than the latest trend. When we do that, we’re far more likely to choose therapies that truly improve our health, not simply those that generate the most attention online.
About the Author
Coach Tony is a Board-Certified Nutrition Specialist and Master Personal Trainer with over 40 years of experience in the health and fitness industry. He specializes in metabolic health, fat loss, and body composition, helping clients restore their metabolism through structured nutrition and resistance training.